WallStreetZenWallStreetZen

NASDAQ: GILD
Gilead Sciences Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Gilead Sciences revenue was $28.75B for the trailing 12 months ending Dec 31, 2024, with -91.6% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $7.6B, up 0.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GILD annual revenue was $28.8B, with 6% growth year-over-year.

GILD past revenue growth

How has GILD's revenue growth performed historically?

Company
6.04%
Industry
14.33%
Market
20.68%
GILD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GILD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GILD's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GILD revenue history

Current Revenue
$28.8B
Current Earnings
$480.0M
Current Profit Margin
1.7%
GILD's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when GILD announces revenue.

GILD Revenue History By Year

GILD Yearly RevenueGILD RevenueGILD ChangeGILD Revenue Growth
2024-12-31$28.75B$1.64B+6.04%
2023-12-31$27.12B-$165.00M-0.60%
2022-12-31$27.28B-$24.00M-0.09%
2021-12-31$27.31B$2.62B+10.60%
2020-12-31$24.69B$2.24B+9.98%
2019-12-31$22.45B$322.00M+1.46%
2018-12-31$22.13B-$3.98B-15.24%
2017-12-31$26.11B-$4.28B-14.09%
2016-12-31$30.39B-$2.25B-6.89%
2015-12-31$32.64B$7.75B+31.13%
2014-12-31$24.89B$13.69B+122.19%
2013-12-31$11.20B$1.50B+15.46%
2012-12-31$9.70B$1.32B+15.70%
2011-12-31$8.39B$435.97M+5.48%
2010-12-31$7.95B$938.04M+13.38%
2009-12-31$7.01B$1.68B+31.40%
2008-12-31$5.34B$1.11B+26.14%
2007-12-31$4.23B$1.20B+39.78%
2006-12-31$3.03B$997.74M+49.19%
2005-12-31$2.03B$703.78M+53.13%
2004-12-31$1.32B$456.76M+52.63%
2003-12-31$867.86M$401.07M+85.92%
2002-12-31$466.79M$233.02M+99.68%
2001-12-31$233.77M$38.21M+19.54%
2000-12-31$195.56M$26.58M+15.73%
1999-12-31$168.98M$17.86M+11.82%
1998-12-31$151.12M$18.86M+14.26%
1997-12-31$132.26M$98.84M+295.75%
1996-12-31$33.42M$28.50M+578.99%
1995-03-31$4.92MN/AN/A

1 of 2

Gilead Sciences Revenue FAQ

What was GILD's revenue last quarter?

On Invalid Date, Gilead Sciences (NASDAQ: GILD) reported Q4 2024 revenue of $7.57 billion up 6.4% year over year. In the same quarter last year, Gilead Sciences's revenue was $7.11 billion.

What was Gilead Sciences's revenue in 2024?

Gilead Sciences's annual revenue for the twelve months ending Dec 31, 2024 was $28.75 billion, a 6.04% increase year over year.

How much does Gilead Sciences make in a day?

Based on Gilead Sciences annual revenue for the past five years, GILD makes an average of $74,052,054.79 per day.

What was Gilead Sciences's annual revenue growth in the past year?

As of Q2 2025, Gilead Sciences's revenue has grown 6.04% year over year. This is 8.29 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 14.33%. Gilead Sciences's revenue in the past year totaled $28.75 billion.

How much does Gilead Sciences make in a year?

Gilead Sciences's revenue by year for the past five years is:
  • Gilead Sciences's revenue for the twelve months ending Dec 31, 2024 was $28.75 billion, a 6.04% increase year over year.
  • Gilead Sciences's annual revenue for Dec 31, 2023 was $27.12 billion, a 0.6% decrease from 2022.
  • Gilead Sciences's annual revenue for 2022 was $27.28 billion, a 0.09% decrease from 2021.
  • Gilead Sciences's annual revenue for 2021 was $27.31 billion, a 10.6% increase from 2020.
  • Gilead Sciences's annual revenue for 2020 was $24.69 billion, a 9.98% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.